CT Group has established Vietnam Gene & Cell Technology Joint Stock Company (VGCT) to select, apply and develop gene and stem cell technology for patients in Vietnam and the surrounding regions. In particular, on June 2022, VGCT officially launched a Scientific Research Center in Israel to research and apply the world’s latest advanced medical and healthcare technologies. With the focus on lung disease and pandemic, this research helps people to prevent the dangerous viruses which will be appeared during climate change.
Other research in tree genes will help the tree grow faster and create more oxygen to control the balance in the nature.
Watch more on VGCT !
Watch more on VGCT !